|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 23, No 22 (August 1), 2005: pp. 4936-4944 © 2005 American Society of Clinical Oncology. DOI: 10.1200/JCO.2005.07.141 Variability and Sample Size Requirements of Quality-of-Life Measures: A Randomized Study of Three Major QuestionnairesFrom the Division of Clinical Trials and Epidemiological Sciences and Departments of Palliative Medicine and Medical Oncology, National Cancer Centre; and Department of Rheumatology and Immunology, Singapore General Hospital, Singapore Address reprint requests to Yin-Bun Cheung, PhD, Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre, 11 Hospital Dr, Singapore 169610; e-mail: cheungyb{at}graduate.hku.hk PURPOSE: To compare the variability and sample size requirements of the global quality-of-life (QOL) scores of the following three major QOL instruments: the Functional Assessment of Cancer TherapyGeneral (FACT-G), Functional Living IndexCancer (FLIC), and European Organisation for Research and Treatment of Cancer Core Quality of Life Questionnaire C30 (EORTC QLQ-C30). PATIENTS AND METHODS: Cancer patients were randomly assigned to answer two of the three instruments using an incomplete block design (n = 1,268). The instruments were compared in terms of coefficient of variation, effect size in detecting a difference between patients with different performance status, and correlation coefficient between scores at baseline and follow-up. RESULTS: The FACT-G and FLIC had significantly smaller coefficients of variation than the EORTC QLQ-C30 (both P < .05). The FLIC also had significantly larger correlation coefficients between scores at baseline and follow-up than the EORTC QLQ-C30 (P < .05). The FACT-G and the FLIC had a larger effect size in a cross-sectional and longitudinal setting, respectively, than the EORTC QLQ-C30 in differentiating patients with different performance status (both P < .05). CONCLUSION: In some aspects, the FACT-G and FLIC global QOL scores had smaller variability and larger discriminative ability than the EORTC QLQ-C30. Further research using other criteria to compare the three instruments is recommended. Supported by research grant No. NMRC/0743/2003 from the National Medical Research Council of Singapore. Authors' disclosures of potential conflicts of interest are found at the end of this article.
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|